CYTOKINE & GROWTH FACTOR REVIEWS

Scope & Guideline

Navigating the Complexities of Endocrinology and Immunology

Introduction

Immerse yourself in the scholarly insights of CYTOKINE & GROWTH FACTOR REVIEWS with our comprehensive guidelines detailing its aims and scope. This page is your resource for understanding the journal's thematic priorities. Stay abreast of trending topics currently drawing significant attention and explore declining topics for a full picture of evolving interests. Our selection of highly cited topics and recent high-impact papers is curated within these guidelines to enhance your research impact.
LanguageEnglish
ISSN1359-6101
PublisherELSEVIER SCI LTD
Support Open AccessNo
CountryUnited Kingdom
TypeJournal
Convergefrom 1996 to 2024
AbbreviationCYTOKINE GROWTH F R / Cytokine Growth Factor Rev.
Frequency6 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address125 London Wall, London EC2Y 5AS, ENGLAND

Aims and Scopes

The journal 'Cytokine & Growth Factor Reviews' focuses on the intricate roles that cytokines and growth factors play in various biological processes and diseases. It aims to foster understanding through comprehensive reviews that integrate findings from molecular biology, immunology, and therapeutic applications.
  1. Cytokine Biology:
    The journal investigates the diverse roles of cytokines in immune response modulation, inflammation, and cell signaling pathways, emphasizing their implications in health and disease.
  2. Growth Factor Signaling:
    Research covers the mechanisms by which growth factors influence cellular processes such as differentiation, proliferation, and survival, particularly in the context of cancer and tissue repair.
  3. Intercellular Communication:
    Exploring the mechanisms of intercellular communication mediated by cytokines and growth factors, including the roles of extracellular vesicles and their impact on tumor microenvironments.
  4. Therapeutic Applications:
    The journal highlights the therapeutic potential of targeting cytokine and growth factor pathways, particularly in cancer immunotherapy, autoimmune diseases, and chronic inflammatory conditions.
  5. Translational Research:
    It emphasizes the translation of basic research findings into clinical applications, providing insights into biomarker discovery and personalized medicine approaches.
Recent publications in 'Cytokine & Growth Factor Reviews' reveal several emerging trends that reflect the evolving landscape of cytokine and growth factor research.
  1. Cancer Immunotherapy:
    A significant increase in research related to cytokines and growth factors in cancer immunotherapy, highlighting the importance of immune modulation in enhancing treatment efficacy.
  2. Neuroinflammation and Neurological Disorders:
    Emerging interest in the role of cytokines in neuroinflammation, particularly concerning conditions like stroke and neurodegenerative diseases, showcases a growing recognition of their impact on neurological health.
  3. Extracellular Vesicles:
    Research focusing on extracellular vesicles as mediators of communication in tumor microenvironments and their role in immune regulation is gaining traction, indicating a shift towards understanding cell-to-cell interactions.
  4. Aging and Senescence:
    An increasing number of studies are addressing the implications of cytokines in aging and cellular senescence, emphasizing their roles in age-related diseases and potential therapeutic interventions.
  5. Metabolic Regulation:
    There is a rising trend in exploring the intersections between cytokine signaling, metabolism, and chronic diseases, reflecting a broader understanding of the systemic effects of cytokines.

Declining or Waning

While 'Cytokine & Growth Factor Reviews' has maintained a robust focus on various themes, certain areas have shown signs of declining interest based on recent publications.
  1. Traditional Immune Pathways:
    There has been a noticeable decrease in papers focusing on classical immune pathways that were previously predominant, suggesting a shift towards more complex and nuanced interactions involving cytokines and growth factors.
  2. Basic Cytokine Function Studies:
    Research centered solely on the basic functions of individual cytokines without considering their interactions or roles in disease contexts seems to be waning, reflecting a trend towards integrative approaches.
  3. Non-Inflammatory Roles of Cytokines:
    Themes exploring the non-inflammatory roles of cytokines, such as their effects on metabolic processes, appear less frequently, indicating a potential narrowing of focus within the journal.

Similar Journals

INTERNATIONAL IMMUNOLOGY

Pioneering Research at the Intersection of Immunology and Medicine.
Publisher: OXFORD UNIV PRESSISSN: 0953-8178Frequency: 12 issues/year

INTERNATIONAL IMMUNOLOGY, published by OXFORD UNIV PRESS, stands out as a premier journal in the field of immunology, providing a vital platform for disseminating groundbreaking research and innovative developments within the discipline. With an impressive Q1 ranking in Immunology and Allergy, as well as in Medicine (miscellaneous), it consistently showcases high-impact studies that contribute to the advancement of immunological knowledge. The journal spans over three decades, from its inception in 1989 to its ongoing contributions as of 2024, thus solidifying its reputation in the scientific community. Researchers, professionals, and students will find valuable articles that delve into the complexities of immune responses, therapeutic interventions, and emerging immunological paradigms, ensuring INTERNATIONAL IMMUNOLOGY remains at the forefront of knowledge in the life sciences.

BIOSCIENCE REPORTS

Your Gateway to Cutting-Edge Scientific Discoveries
Publisher: PORTLAND PRESS LTDISSN: 0144-8463Frequency: 6 issues/year

BIOSCIENCE REPORTS, published by Portland Press Ltd, is a prestigious journal dedicated to advancing the fields of biochemistry, biophysics, cell biology, and molecular biology. Founded in 1981, the journal has established itself as a vital resource for researchers and professionals, boasting a significant impact factor and high rankings within its categories, including Q2 in Biochemistry and Q1 in Biophysics as of 2023. The journal’s commitment to high-quality, peer-reviewed research ensures that it remains an influential platform for the dissemination of cutting-edge scientific findings. While it operates under a traditional subscription model, it offers various access options to accommodate the needs of the scientific community. With ongoing publication through 2024, BIOSCIENCE REPORTS continues to play a crucial role in shaping discussions in the life sciences and fostering innovative research in biology.

CYTOTECHNOLOGY

Exploring Cytotechnological Frontiers: Where Research Meets Application.
Publisher: SPRINGERISSN: 0920-9069Frequency: 6 issues/year

CYTOTECHNOLOGY, an esteemed journal published by Springer, stands as a vital resource in the fields of Bioengineering, Biomedical Engineering, and Biotechnology. With an impact factor reflective of its solid position within academia, this journal encompasses a broad scope dedicated to the advancement of cytotechnological research and applications from its inception in 1987 through to its latest volumes in 2024. Based in the Netherlands, it is committed to providing researchers, professionals, and students with high-quality, peer-reviewed articles that contribute to the understanding and innovations in cytotechnology. Although currently not open access, CYTOTECHNOLOGY has garnered a commendable reputation, holding Q3 rankings in multiple categories, indicating its relevance and influence within the scientific community. Researchers are encouraged to submit their cutting-edge findings to share insights that can spark further advancements in this dynamic field.

Genes & Diseases

Connecting genetics to disease for transformative insights.
Publisher: KEAI PUBLISHING LTDISSN: 2352-4820Frequency: 6 issues/year

Genes & Diseases, published by KEAI PUBLISHING LTD, is a premier open-access journal dedicated to advancing the fields of genetics, biochemistry, and molecular biology. Established in 2014 and headquartered in Beijing, China, this journal has quickly risen to prominence, securing a place in the prestigious Q1 quartile in Biochemistry and Genetics (clinical), as well as Q2 in Cell Biology and Q1 in Molecular Biology as of 2023. With a commitment to disseminating cutting-edge research, Genes & Diseases serves as a critical platform for researchers, professionals, and students alike, ensuring that high-quality scientific work is openly accessible to the global community. The journal's exceptional impact is underscored by its selective Scopus rankings, which reflect its influence and relevance in key scientific domains, making it an essential resource for those exploring the intersections of genetics and disease pathology.

CELL DEATH AND DIFFERENTIATION

Exploring the Frontiers of Cellular Dynamics
Publisher: SPRINGERNATUREISSN: 1350-9047Frequency: 12 issues/year

CELL DEATH AND DIFFERENTIATION, published by SpringerNature, is a leading peer-reviewed journal that has been at the forefront of advancing knowledge in the fields of cell biology and molecular biology since its inception in 1994. With an impressive impact factor and ranking in the Q1 quartile for both categories as of 2023, it is recognized as an essential resource for researchers and professionals dedicated to understanding the intricate processes of cellular death and differentiation. The journal publishes high-quality original research articles, reviews, and commentaries, fostering an interdisciplinary dialogue among scientists exploring the molecular mechanisms that underpin these fundamental biological processes. With its commitment to excellence, CEL DEATH AND DIFFERENTIATION bridges gaps in knowledge and stimulates innovation within the scientific community. To access cutting-edge research from this prestigious journal, you may visit their website for subscription options and explore a wealth of knowledge that is crucial for advancing the frontiers of biological research.

JOURNAL OF IMMUNOLOGY

Empowering the Future of Immune Research
Publisher: AMER ASSOC IMMUNOLOGISTSISSN: 0022-1767Frequency: 24 issues/year

Welcome to the JOURNAL OF IMMUNOLOGY, a prestigious publication associated with the American Association of Immunologists and dedicated to advancing the field of immunology. With a rich history dating back to 1945, this journal is renowned for its high-impact research, evident in its notable 2023 Q1 rankings in both Immunology and Allergy, as well as its strong positions in Scopus rankings—Rank #68 in Immunology and Allergy and Rank #79 in Immunology and Microbiology. Although it operates on a subscription basis, its commitment to publishing cutting-edge studies ensures that it remains a vital resource for scientists, healthcare professionals, and students alike. As the journal continues to pave the way for innovative research and breakthroughs in immunological science, it facilitates a platform for dialogue and discovery among researchers and practitioners across the globe.

CELLULAR & MOLECULAR BIOLOGY LETTERS

Fostering Collaboration in the World of Molecular Discoveries
Publisher: BMCISSN: 1425-8153Frequency: 1 issue/year

CELLULAR & MOLECULAR BIOLOGY LETTERS, published by BMC, is a premier open-access journal dedicated to disseminating high-quality research in the fields of Biochemistry, Cell Biology, and Molecular Biology. Established in 1996, the journal has emerged as a leader in its domain, boasting an impressive Q1 ranking across three critical categories as of 2023, reflecting its significant impact within the scientific community. With an ISSN of 1425-8153 and an E-ISSN of 1689-1392, it offers accessible research findings to a global audience, having been open access since 2013. Situated in the United Kingdom, at CAMPUS, 4 CRINAN ST, LONDON N1 9XW, the journal continues to serve as a vital resource for researchers, professionals, and students, contributing to advancements in the understanding of cellular and molecular processes. By providing a platform for original research, reviews, and short communications, CELLULAR & MOLECULAR BIOLOGY LETTERS plays a crucial role in fostering dialogue and collaboration within the scientific community.

JOURNAL OF EXPERIMENTAL MEDICINE

Elevating Experimental Medicine to New Heights
Publisher: ROCKEFELLER UNIV PRESSISSN: 0022-1007Frequency: 12 issues/year

JOURNAL OF EXPERIMENTAL MEDICINE, published by Rockefeller University Press, is a renowned peer-reviewed journal dedicated to advancing the field of experimental medicine since its inception in 1896. With an impressive impact factor and categorized in the Q1 quartile for Immunology, Immunology and Allergy, and Miscellaneous Medicine, this journal stands at the forefront of medical research and innovation. It provides a prestigious platform for scholars and practitioners to disseminate groundbreaking findings that drive the understanding of disease mechanisms and therapeutic strategies. While the journal is not open access, it maintains high visibility and engagement within the scientific community, fostering collaboration among researchers, professionals, and students alike. The journal's consistent ranking in the top percentiles of Scopus illustrates its significant impact and commitment to excellence in medical research.

FOLIA BIOLOGICA

Fostering Discovery in Life Sciences
Publisher: CHARLES UNIV PRAGUE, FIRST FACULTY MEDICINEISSN: 0015-5500Frequency: 6 issues/year

FOLIA BIOLOGICA, published by Charles University Prague, First Faculty of Medicine, is an esteemed academic journal that has been contributing to the fields of Biochemistry, Cell Biology, Developmental Biology, Genetics, Immunology, and Molecular Biology since its inception in 1961. With an ISSN of 0015-5500, this journal serves as a vital platform for researchers and professionals to disseminate their findings and advance knowledge within these disciplines. Despite its current Category Quartiles ranking in the lower tiers (Q3 and Q4), FOLIA BIOLOGICA continues to provide valued insights and foster scholarly dialogue, particularly in its paralleled fields. The journal is headquartered in Prague, Czech Republic, and operates without Open Access options, which emphasizes its focus on curated, peer-reviewed content essential for academicians and students. By bridging theoretical and practical knowledge, FOLIA BIOLOGICA remains committed to enriching the scientific community and serving as a cornerstone for future research innovations.

JOURNAL OF MOLECULAR MEDICINE-JMM

Unveiling the Molecular Mysteries of Health and Disease.
Publisher: SPRINGER HEIDELBERGISSN: 0946-2716Frequency: 12 issues/year

JOURNAL OF MOLECULAR MEDICINE (JMM) is a premier publication dedicated to advancing the field of molecular medicine, encompassing critical areas such as drug discovery, genetics, and biochemistry. Published by Springer Heidelberg in Germany, this influential journal has established its significance within the academic community, achieving an impressive Q1 ranking across multiple categories as of 2023, including Drug Discovery, Clinical Genetics, and Molecular Medicine. With a focus on publishing high-quality research and novel insights, JMM appeals to a diverse audience of researchers, professionals, and students passionate about the molecular underpinnings of health and disease. The journal, which has seen a convergence of relevant research spanning from 1976 to 2024, is instrumental in showcasing groundbreaking studies that push the boundaries of knowledge in molecular therapeutics and biomedical science. While it does not offer open access, the rigor of its peer-reviewed content ensures that each publication is a valuable addition to the scientific discourse surrounding molecular medicine. For comprehensive studies and reviews that highlight the intersection of molecular biology and clinical application, look no further than JOURNAL OF MOLECULAR MEDICINE.